Compare ABEV & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABEV | VEEV |
|---|---|---|
| Founded | 1885 | 2007 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.4B | 36.9B |
| IPO Year | N/A | 2013 |
| Metric | ABEV | VEEV |
|---|---|---|
| Price | $2.79 | $222.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 26 |
| Target Price | $2.53 | ★ $303.52 |
| AVG Volume (30 Days) | ★ 22.8M | 1.5M |
| Earning Date | 02-12-2026 | 03-04-2026 |
| Dividend Yield | ★ 6.90% | N/A |
| EPS Growth | 15.78 | ★ 26.69 |
| EPS | 0.19 | ★ 5.13 |
| Revenue | ★ $16,975,691,794.00 | $3,080,246,000.00 |
| Revenue This Year | $3.57 | $17.74 |
| Revenue Next Year | $4.38 | $12.28 |
| P/E Ratio | ★ $14.59 | $43.27 |
| Revenue Growth | 9.79 | ★ 15.96 |
| 52 Week Low | $1.79 | $201.54 |
| 52 Week High | $2.81 | $310.50 |
| Indicator | ABEV | VEEV |
|---|---|---|
| Relative Strength Index (RSI) | 75.16 | 43.71 |
| Support Level | $2.56 | $215.55 |
| Resistance Level | $2.61 | $226.64 |
| Average True Range (ATR) | 0.05 | 7.12 |
| MACD | 0.03 | 0.28 |
| Stochastic Oscillator | 95.83 | 23.20 |
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.